This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hanlim Pharmaceutical Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Jae-Chun Ryu: Innovator in Pharmaceutical Purification
Introduction
Jae-Chun Ryu is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of chemical compounds. His work is characterized by a focus on innovative methods that enhance the quality and efficacy of pharmaceutical products.
Latest Patents
Jae-Chun Ryu holds a patent for a method for purifying a benzopyran derivative, specifically titled "Method for purifying benzopyran derivative, crystal form thereof, and method for preparing crystal form." This invention provides a process for converting an amorphous compound into a crystalline form, which is crucial for improving the stability and bioavailability of the drug. The patent details a novel crystalline form of the compound and outlines the processes for preparing it.
Career Highlights
Ryu is currently employed at Hanlim Pharmaceutical Co., Ltd., where he continues to develop innovative solutions in the pharmaceutical industry. His expertise in chemical processes has positioned him as a valuable asset to his company and the broader scientific community.
Collaborations
Throughout his career, Jae-Chun Ryu has collaborated with esteemed colleagues, including Yong-Kyun Park and Hyun-Kyu Kim. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Jae-Chun Ryu's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to enhancing drug purification processes. His work not only benefits his company but also advances the pharmaceutical industry as a whole.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile